<p>雀巢印度的股票在週五開盤交易中上漲了最多 2.5%，延續了昨日的漲幅，此前這家快速消費品巨頭的 2026 財年第二季度業績在銷售和盈利方面均超出預期。包括中信證券、摩根士丹利和滙豐在內的券商承認公司的強勁銷量驅動增長，但對利潤率和估值的前景看法不一。</p>
<p>截至上午 9:25，雀巢印度的股票在國家證券交易所的交易價格為 1,289 盧比，比前一交易日上漲了 1%。該股票在週四的收盤價上漲了 3.5%，在業績發佈後，其年初至今的漲幅超過了 17%。雀巢印度第二季度業績：儘管利潤下降，銷售勢頭依然穩定。</p>
<p>雀巢印度的單獨淨利潤同比下降 23.6%，降至 753.2 億盧比，儘管仍高於市場普遍預期。運營收入增長 10.6%，達到 5,643.6 億盧比，主要得益於廣泛的國內需求。國內銷售增長 10.8%，達到 5,411 億盧比，創下公司歷史最高季度數字。增長得益於主要品牌的強勁表現——Maggi、KitKat 和 Nescafe 均實現了兩位數的銷量增長。息税折舊攤銷前利潤（EBITDA）利潤率佔銷售額的 22%，管理層指出成本通脹正在減緩，消費者需求依然強勁。券商對雀巢印度的股票估值和利潤率看法不一。</p>
<ul>
<li>中信證券表示，公司在銷售和盈利方面均 “超出預期”，並指出在挑戰性市場條件下，國內銷量驅動的強勁增長和好於預期的利潤。</li>
<li>摩根士丹利在注意到盈利超預期的同時，對雀巢印度的股票給予了減持評級，目標價為每股 1,010 盧比。它指出，毛利率同比下降 216 個基點至 54.2%，而 EBITDA 利潤率下降 124 個基點至 21.1%。該券商表示，管理層預計牛奶價格將趨於平穩，咖啡價格將穩定，儘管食用油可能仍將保持通脹狀態。</li>
<li>滙豐則給予持有評級，目標價為每股 1,260 盧比。它將本季度描述為 “強勁，儘管受到干擾，收入同比增長 11%。” 它指出，四個產品細分中有三個實現了兩位數的銷量增長，其中 Maggi 表現尤為突出，並補充説成本通脹壓力正在減輕。</li>
</ul>
<p>免責聲明：Moneycontrol.com 上的投資專家所表達的觀點和投資建議僅代表他們個人的看法，並不代表該網站或其管理層的觀點。Moneycontrol.com 建議用户在做出任何投資決策之前諮詢認證專家。</p>

雀巢(ADR)

雀巢

<p>雀巢印度的股票在 2026 財年第二季度業績超出預期後上漲了 2.5%，儘管利潤下降了 23.6% 至 753.2 億盧比，但收入增長了 10.6%，達到了 5643.6 億盧比。像 CLSA 這樣的券商讚揚了強勁的銷量增長，而摩根士丹利則給予了減持評級，指出了利潤率壓力。滙豐維持了持有評級，強調了主要品牌的強勁表現。該股票的交易價格為 1289 盧比，使其年初至今的漲幅超過 17%</p>

<p>Nestle India shares rose as much 2.5 percent in the opening trade on Friday, extending yesterday's gain, after the FMCG major’s Q2 FY26 results surpassed expectations on both sales and profitability. Brokerages including CLSA, Morgan Stanley, and HSBC acknowledged the company’s strong volume-led growth but differed in their outlook on margins and valuations.</p>
<div class="lb-trans"><p>雀巢印度的股票在週五開盤交易中上漲了最多 2.5%，延續了昨日的漲幅，此前這家快速消費品巨頭的 2026 財年第二季度業績在銷售和盈利方面均超出預期。包括中信證券、摩根士丹利和滙豐在內的券商承認公司的強勁銷量驅動增長，但對利潤率和估值的前景看法不一。</p>
</div><p>Nestle India stock was trading at Rs 1,289 on NSE at 9:25 am, up 1 percent from the previous close. The stock had closed 3.5 percent higher on Thursday following the results, extending its year-to-date gain to over 17 percent. Nestle India Q2 results: steady sales momentum despite profit decline</p>
<div class="lb-trans"><p>截至上午 9:25，雀巢印度的股票在國家證券交易所的交易價格為 1,289 盧比，比前一交易日上漲了 1%。該股票在週四的收盤價上漲了 3.5%，在業績發佈後，其年初至今的漲幅超過了 17%。雀巢印度第二季度業績：儘管利潤下降，銷售勢頭依然穩定。</p>
</div><p>Nestle India’s standalone net profit fell 23.6 percent year-on-year to Rs 753.2 crore, though still ahead of consensus estimates. Revenue from operations climbed 10.6 percent to Rs 5,643.6 crore, led by broad-based domestic demand. Domestic sales rose 10.8 percent to Rs 5,411 crore, the company’s highest-ever quarterly figure.The growth was powered by robust performances across key brands -- Maggi, KitKat, and Nescafe -- all posting double-digit volume gains. EBITDA margin stood at 22 percent of sales, while management noted that cost inflation was moderating and consumer demand remained firm.Brokerages divided on Nestle India stock valuation and margins</p>
<div class="lb-trans"><p>雀巢印度的單獨淨利潤同比下降 23.6%，降至 753.2 億盧比，儘管仍高於市場普遍預期。運營收入增長 10.6%，達到 5,643.6 億盧比，主要得益於廣泛的國內需求。國內銷售增長 10.8%，達到 5,411 億盧比，創下公司歷史最高季度數字。增長得益於主要品牌的強勁表現——Maggi、KitKat 和 Nescafe 均實現了兩位數的銷量增長。息税折舊攤銷前利潤（EBITDA）利潤率佔銷售額的 22%，管理層指出成本通脹正在減緩，消費者需求依然強勁。券商對雀巢印度的股票估值和利潤率看法不一。</p>
</div><ul>
<li>CLSA said the company “beat estimates on both sales and profitability,” citing strong volume-driven domestic growth and better-than-expected profit in challenging market conditions.</li>
<li>Morgan Stanley, while noting the earnings beat, shared an underweight call on Nestle India stock with a target price of Rs 1,010 per share. It pointed out that the gross margin fell 216 basis points year-on-year to 54.2 percent and EBITDA margin declined 124 basis points to 21.1 percent. The brokerage said management expects milk prices to soften and coffee prices to stabilise, though edible oil may remain inflationary.</li>
<li>HSBC has a hold rating with a target price of Rs 1,260 per share. It described the quarter as “strong with 11 percent year-on-year revenue growth in a disrupted quarter.” It noted that three of four product segments posted double-digit, volume-led growth, with Maggi being the standout surprise, and added that cost inflation pressures are easing.</li>
</ul>
<div class="lb-trans"><ul>
<li>中信證券表示，公司在銷售和盈利方面均 “超出預期”，並指出在挑戰性市場條件下，國內銷量驅動的強勁增長和好於預期的利潤。</li>
<li>摩根士丹利在注意到盈利超預期的同時，對雀巢印度的股票給予了減持評級，目標價為每股 1,010 盧比。它指出，毛利率同比下降 216 個基點至 54.2%，而 EBITDA 利潤率下降 124 個基點至 21.1%。該券商表示，管理層預計牛奶價格將趨於平穩，咖啡價格將穩定，儘管食用油可能仍將保持通脹狀態。</li>
<li>滙豐則給予持有評級，目標價為每股 1,260 盧比。它將本季度描述為 “強勁，儘管受到干擾，收入同比增長 11%。” 它指出，四個產品細分中有三個實現了兩位數的銷量增長，其中 Maggi 表現尤為突出，並補充説成本通脹壓力正在減輕。</li>
</ul>
</div><p>Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.</p>
<div class="lb-trans"><p>免責聲明：Moneycontrol.com 上的投資專家所表達的觀點和投資建議僅代表他們個人的看法，並不代表該網站或其管理層的觀點。Moneycontrol.com 建議用户在做出任何投資決策之前諮詢認證專家。</p>
</div>

雀巢印度股價今日上漲，因第二季度業績超預期；分析師指出儘管銷售強勁且成本下降，但利潤率仍面臨壓力